SUBSCRIBE
SUBSCRIBE
News   Drug Development

BioMS Medical Announces Second Quarter 2006 Results

August 14, 2006 | 
1 min read

BioMS Medical Corp (“BioMS” or the “Corporation”) (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced financial and operational results for the second quarter ended June 30, 2006.

Clinical research Phase II Phase III Earnings
MORE ON THIS TOPIC
Pictured: GSK laboratories in Dresden, Germany
Earnings
GSK Looks to Deal in Cancer, Respiratory, Inflammation in 2025
February 5, 2025
 · 
2 min read
 · 
Tristan Manalac
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Earnings
Pipeline Problems Mar Amgen’s Q4 Beat
February 5, 2025
 · 
3 min read
 · 
Tristan Manalac
Podcast
RFK Jr. Advances, Q4 Earnings Roll Out and a Non-Opioid Pain Drug Hits the Market
February 5, 2025
 · 
1 min read
 · 
Heather McKenzie
Brussels, Belgium. 21st December 2020. Exterior view of Pfizer Pharmaceutical company's offices.
Earnings
Pfizer Eyes Deals up to $15B, With ‘Fruitful’ China Discussions Ongoing
February 4, 2025
 · 
4 min read
 · 
Annalee Armstrong